Laventatug, CAS 3009829-91-5

Product Description: Laventatug is a humanized monoclonal antibody targeting human SLC39A6. Laventatug specifically binds to SLC39A6, interfering with the intracellular zinc ion transport process and thus exerting antitumor activity. Laventatug is promising for research of cancers[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 3009829-91-5

Molecular Weight: N/A

Research Area: Cancer

Target: SLC39 (Zinc Transporter)

• Artikelnummer: MEXHY-P991145-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991145-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated